Canada markets open in 1 hour 46 minutes

Amneal Pharmaceuticals, Inc. (AMRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.12+0.07 (+1.16%)
At close: 04:00PM EDT
5.99 -0.13 (-2.12%)
After hours: 07:10PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.89B
Enterprise Value 4.55B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.45
Price/Book (mrq)95.38
Enterprise Value/Revenue 1.90
Enterprise Value/EBITDA 11.37

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 3232.61%
S&P500 52-Week Change 323.57%
52 Week High 36.46
52 Week Low 31.74
50-Day Moving Average 35.72
200-Day Moving Average 34.81

Share Statistics

Avg Vol (3 month) 31.58M
Avg Vol (10 day) 31.71M
Shares Outstanding 5308.55M
Implied Shares Outstanding 6316.4M
Float 8135.69M
% Held by Insiders 155.79%
% Held by Institutions 129.19%
Shares Short (Apr 15, 2024) 42.8M
Short Ratio (Apr 15, 2024) 41.58
Short % of Float (Apr 15, 2024) 41.09%
Short % of Shares Outstanding (Apr 15, 2024) 40.91%
Shares Short (prior month Mar 15, 2024) 42.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -3.51%
Operating Margin (ttm)13.19%

Management Effectiveness

Return on Assets (ttm)4.66%
Return on Equity (ttm)-36.06%

Income Statement

Revenue (ttm)2.39B
Revenue Per Share (ttm)13.59
Quarterly Revenue Growth (yoy)1.20%
Gross Profit (ttm)N/A
EBITDA 500.78M
Net Income Avi to Common (ttm)-83.99M
Diluted EPS (ttm)-0.48
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)93.74M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)2.75B
Total Debt/Equity (mrq)4,486.69%
Current Ratio (mrq)1.63
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)345.58M
Levered Free Cash Flow (ttm)303.9M